I think the market will likely yawn about the financial performance in Q4, especially with this statement from the MD&A "The reduction in Q4 sales was a result of backlog pushed into Q1 2017 due to production challenges with one large customer. Expected Q4 NRE was also delayed and will not be recognized until Q1 2017". I would assume this looks good for Q1.

Hopefully the market likes "Validated the functionality of VCSELs", but given history about the market's reaction to achieved milestones, likely another yawn. I do find that very encouraging, definitely for the medium to longer term. Let's get a prototype (POET technology) into potential customer's hands, and hope that does something.

Good luck!!